- Trials with a EudraCT protocol (470)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
470 result(s) found for: Anticoagulation.
Displaying page 1 of 24.
EudraCT Number: 2005-001007-18 | Sponsor Protocol Number: 2989 | Start Date*: 2005-06-03 |
Sponsor Name:Royal Victoria Infirmary | ||
Full Title: Reversal of warfarin anticoagulation with oral vitamin K: towards a better management of over-anticoagulation | ||
Medical condition: Patients with thromboembolic disorders are anticogulated with warfarin. However excessive over-anticoagulation can increase the patient risk of bleeding. Oral vitamin K is routinely used for revers... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005410-19 | Sponsor Protocol Number: HH-AT-001 | Start Date*: 2013-03-11 | |||||||||||
Sponsor Name:Jessaziekenhuis Hasselt | |||||||||||||
Full Title: Developing a Patient Model of Controlled, Radial Artery Access Site Bleeding for Deciding on Anticoagulation Reversal in Patients Treated by Systemic Anticoagulants. | |||||||||||||
Medical condition: With the novel oral anticoagulants, including EDOXABAN-DABIGATRANRIVAROXABAN- APIXABAN, we are entering a new era of anticoagulation for atrial fibrillation (AF) (and deep vein thrombosis). Neve... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021813-22 | Sponsor Protocol Number: 781875 | Start Date*: 2010-12-23 | |||||||||||
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: The Anticoagulation of Calf Thrombosis (ACT) Study: A randomised controlled trial comparing standardised anticoagulation versus conservative therapy in the treatment of below knee deep vein thrombo... | |||||||||||||
Medical condition: DVT of the calf / below knee region. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006238-87 | Sponsor Protocol Number: 4717 | Start Date*: 2010-01-22 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K | ||
Medical condition: Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-000042-31 | Sponsor Protocol Number: ArgatrobanHDF01 | Start Date*: 2008-09-04 |
Sponsor Name:Univ. Klinik f. Anästhesie, Intensivmedizin und Schmerztherapie | ||
Full Title: Anticoagulation with argatroban and prostacyclin compared to unfractionated heparin and prostacyclin during continous venovenous haemodialfiltation: a crossover trial | ||
Medical condition: Anticoagulation with argatroban and prostacyclin compared to unfractionated heparin and prostacyclin during continous venovenous haemodiafiltarion: a crossover trial | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003086-25 | Sponsor Protocol Number: 201600620 | Start Date*: 2017-04-19 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: More precise dosing of acenocoumarol in patients aged 80 and above, a pilot study | ||
Medical condition: atrial fibrillation venous thrombo-embolism heart valve repair other diseases with an indication for anticoagulation with vitamin K antagonists | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000382-19 | Sponsor Protocol Number: BE1116_3001 | Start Date*: 2005-09-15 | |||||||||||
Sponsor Name:ZLB Behring GmbH | |||||||||||||
Full Title: Efficacy and tolerance of BERIPLEX® P/N in subjects with acquired deficiency of coagulation factors II, VII, IX and X due to oral anticoagulation | |||||||||||||
Medical condition: Acquired deficiency of coagulation factors II, VII, IX and X due to oral anticoagulation requiring an immediate reversal of anticoagulant effect (i.e. emergency surgery or acute bleeding). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) HU (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002259-20 | Sponsor Protocol Number: CASUAL_ECMO | Start Date*: 2023-08-17 |
Sponsor Name:Medical University of Vienna | ||
Full Title: A three-arm randomized controlled non-inferiority pilot study Comparing Anticoagulation Strategies using Unfractionated heparin, Argatroban and Low-molecular-weight heparin for Extracorporeal Memb... | ||
Medical condition: patients with indication for extracorporeal membrane oxygenation therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004125-24 | Sponsor Protocol Number: NL6979 | Start Date*: 2020-07-02 |
Sponsor Name:UMCG | ||
Full Title: Reduced Anticoagulation Targets in Extracorporeal life support | ||
Medical condition: Heart or lungfailure treated with ECMO | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000353-26 | Sponsor Protocol Number: SAFE-SSPE | Start Date*: 2021-09-20 |
Sponsor Name:Bern University Hospital | ||
Full Title: Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Placebo-Controlled Non-Inferiority Trial | ||
Medical condition: Isolated subsegmental pulmonary embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006887-12 | Sponsor Protocol Number: HEPACO | Start Date*: 2011-12-07 |
Sponsor Name:Institut de Recerca HSCSP | ||
Full Title: Randomized controlled trial to compare treatment with oral anticoagulation with vitamin K antagonists versus low molecular weight heparin (bemiparin) in patients with anticoagulation criteria and h... | ||
Medical condition: Patients with gastrointestinal bleeding are not candidates for endoscopic treatment with oral anticoagulant previously. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005206-31 | Sponsor Protocol Number: 2006-09 | Start Date*: 2007-01-25 |
Sponsor Name:Örebro University Hospital | ||
Full Title: Perioperative Morbidity in Elderly patients undergoing Surgery for Fracture Neck of Femur. The Effect of Plasma or Ocplex® for reversal of Warfarin anticoagulation. | ||
Medical condition: Patients undergoing surgery for the repair of fracture neck of femur that are on chronic oral warfarin sodium as anticoagulation prophylactics. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005617-39 | Sponsor Protocol Number: WS2030571 | Start Date*: 2014-01-14 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy | ||
Medical condition: Surgical ICU patients with severe infection and renal replacement therapy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002649-41 | Sponsor Protocol Number: LEX-209 | Start Date*: 2017-06-19 | |||||||||||
Sponsor Name:Octapharma Pharmazeutika Produktionsges.m.b.H | |||||||||||||
Full Title: A Phase III, randomized, double-blind, multicenter study to assess the efficacy and safety of OCTAPLEX, a four-factor prothrombin complex concentrate (4F-PCC), compared to the 4F-PCC Beriplex® P/N ... | |||||||||||||
Medical condition: Reversal of vitamin K antagonist (VKA) induced anticoagulation in patients needing urgent surgery associated with significant bleeding risk. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) PL (Completed) ES (Prematurely Ended) BG (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004361-12 | Sponsor Protocol Number: FER-CIT-2016-01 | Start Date*: 2017-03-27 | ||||||||||||||||
Sponsor Name:Fernando Sánchez | ||||||||||||||||||
Full Title: Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies. Effect of two anticoagulation strategies of ... | ||||||||||||||||||
Medical condition: Acute renal failure (ARF). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000487-23 | Sponsor Protocol Number: ArgHeR | Start Date*: 2012-05-18 | ||||||||||||||||
Sponsor Name:Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin | ||||||||||||||||||
Full Title: A pilot trial to assess the efficacy of Argatroban (Argatra®) in critically ill patients with heparin resistance | ||||||||||||||||||
Medical condition: Heparin resistance in critically ill patients with the need of prophylactic anticoagulation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002504-39 | Sponsor Protocol Number: HERO-19 | Start Date*: 2020-11-10 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Hamburg Edoxaban foR anticoagulation in COvid-19 study | |||||||||||||
Medical condition: COVID-19 [Coronavirus disease 2019] | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001776-21 | Sponsor Protocol Number: NCT00687882 | Start Date*: 2016-03-10 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für | ||
Full Title: Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children | ||
Medical condition: Thrombosis in pediatric patients | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) NL (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2009-012803-24 | Sponsor Protocol Number: REG1-CLIN211 | Start Date*: 2009-10-02 | |||||||||||
Sponsor Name:Regado Biosciences, Inc | |||||||||||||
Full Title: A RANDOMIZED, PARTIALLY-BLINDED, MULTI-CENTER, ACTIVE-CONTROLLED, DOSE RANGING STUDY ASSESSING THE SAFETY, EFFICACY, AND PHARMACODYNAMICS OF THE REG1 ANTICOAGULATION SYSTEM COMPARED TO UNFRACTIONAT... | |||||||||||||
Medical condition: Acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004138-13 | Sponsor Protocol Number: 4976 | Start Date*: 2019-10-16 | |||||||||||
Sponsor Name:THE ROYAL MARSDEN NHS FOUNDATION | |||||||||||||
Full Title: A multicentre phase II non-randomised trial assessing the efficacy of DKN-01 plus atezolizumab in patients with advanced mismatch repair proficient oesophagogastric cancer | |||||||||||||
Medical condition: Patients with advanced mismatch repair proficient oesophagogastric cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.